TGIA
ABBV icon

Torrey Growth & Income Advisors’s AbbVie ABBV Stock Holding History

Torrey Growth & Income Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
4,254
+1
+0% +$215 0.37% 43
2026
Q1 		$921K Buy
4,253
+1
+0% +$222 0.39% 41
2025
Q4 		$972K Sell
4,252
-1,650
-28% -$376K 0.34% 43
2025
Q3 		$1.37M Buy
+5,902
New +$1.2M 0.4% 39

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Torrey Growth & Income Advisors's ABBV Position: Q2 2026 in Review

Torrey Growth & Income Advisors increased its AbbVie (ABBV) stake by 0.02% in Q2 2026, buying an estimated $215 and bringing the position to 4,254 shares worth $1.08M. The position accounts for 0.37% of the portfolio, ranked #43.

Torrey Growth & Income Advisors first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.37M in Q3 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Torrey Growth & Income Advisors held 4,254 shares of AbbVie worth $1.08M as of Q2 2026.
  • Torrey Growth & Income Advisors bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.37% of Torrey Growth & Income Advisors's portfolio in Q2 2026, its #43 holding.
  • Torrey Growth & Income Advisors first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • Torrey Growth & Income Advisors's AbbVie position peaked at $1.37M in Q3 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Torrey Growth & Income Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.